openPR Logo
Press release

Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030, Evaluates DelveInsight | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPo

06-18-2025 10:01 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030,

According to DelveInsight's analysis, the increasing demand for coronary stents is largely driven by the rising incidence of cardiovascular diseases and the growing risk factors linked to coronary artery disease. Moreover, the global surge in minimally invasive surgical procedures, combined with ongoing technological advancements in stent design, are significant contributors to the anticipated growth of the coronary stents market between 2024 and 2030.

DelveInsight's "Coronary Stents Market Insights, Competitive Landscape and Market Forecast-2030" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Coronary Stents companies actively working in the market.

To know more about why North America is leading the market growth in the Coronary Stents market, get a snapshot of the report Coronary Stents Market Trends
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Coronary Stents Overview
Coronary stents are small, mesh-like tubes inserted into narrowed or blocked coronary arteries to keep them open and restore proper blood flow to the heart. They are commonly used during angioplasty procedures to treat coronary artery disease (CAD) and help prevent heart attacks or chest pain. Some stents are drug-eluting, releasing medication to prevent re-narrowing of the artery.

DelveInsight Analysis: The coronary stents market was valued at USD 9.27 billion in 2023 and is projected to grow at a CAGR of 7.51% from 2024 to 2030, reaching USD 14.28 billion by the end of the forecast period.

Coronary Stents Market Insights
Geographically, North America is projected to lead the coronary stents market throughout the forecast period. This leadership is due to the growing incidence of heart-related conditions, increased efforts by governments and organizations to promote awareness about cardiovascular health, and notable technological progress and product innovations by major companies in the region.

To read more about the latest highlights related to Coronary Stents, get a snapshot of the key highlights entailed in the Coronary Stents Market Landscape
https://www.delveinsight.com/report-store/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Coronary Stents Market Report
• In July 2024, BIOTRONIK introduced the Maximum Allowed Diameters (MAD) range for its Orsiro Mission drug-eluting stent (DES) as part of a global initiative to enhance the stent's capabilities. This development supports current percutaneous coronary intervention (PCI) techniques by enabling physicians to achieve better vessel apposition and accommodate tapered anatomies more efficiently.
• In April 2023, Terumo Corporation announced the launch of a new prospective clinical study evaluating the Ultimaster NagomiTM sirolimus-eluting coronary stent system in patients undergoing complex PCI procedures. This stent system retains the sirolimus-eluting drug while featuring an improved delivery mechanism and enhanced effectiveness in treating coronary artery disease. The main objective of the study is to evaluate the clinical outcomes in patients treated with the Ultimaster NagomiTM stent during complex interventions.
• In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems, Inc. for USD 890 million. This strategic move enhances Abbott's portfolio of advanced stent systems and strengthens its technological expertise in interventional vascular devices, supporting broader global market expansion.
• In July 2022, MicroPort Scientific Corporation has received marketing approval from China's National Medical Products Administration (NMPA) for its Firehawk ProTM Coronary Rapamycin Target Eluting Stent System. Designed with a balloon-expandable structure and a groove-binding, single-sided drug coating, this advanced stent system is intended for treating symptomatic primary coronary artery lesions. The drug coating works to prevent smooth muscle cell growth at the lesion site, aiding in arterial support and minimizing the risk of restenosis.
• Thus, owing to such developments in the market, rapid growth will be observed in the Coronary Stents market during the forecast period

Key Players in the Coronary Stents Market
Some of the key market players operating in the Coronary Stents market include- Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others.

Which MedTech key players in the Coronary Stents market are set to emerge as the trendsetter explore @ Key Coronary Stents Companies
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Coronary Stents Market Landscape
The rising adoption of minimally invasive procedures like coronary angioplasty and percutaneous coronary intervention (PCI) plays a key role in driving the growth of the coronary stent market. According to data released by Eurostat, the European Union's statistical office, in October 2023, around 1.1 million percutaneous coronary angioplasty procedures were carried out across Europe in 2021.

Recent product approvals are anticipated to boost the coronary stent market's growth. Leading companies are ramping up research and development to introduce advanced drug-eluting stents for managing coronary artery disease (CAD). For instance, in August 2022, Medtronic launched the Onyx FrontierTM, its latest drug-eluting stent, following CE Mark approval. This stent features an enhanced delivery system and builds on the clinical success of the Resolute OnyxTM. Specifically designed for CAD patients-who suffer from plaque accumulation in the coronary arteries-such innovations are expected to improve treatment outcomes and significantly contribute to market expansion.

Scope of the Coronary Stents Market Report
• Coverage: Global
• Study Period: 2021-2030
• Coronary Stents Market Segmentation By Product Type: Bare Metal Stents, Drug Eluting Stents, and Bioresorbable Scaffolds), Material (Metal [Stainless Steel, Cobalt-Chromium {CoCr}, Platinum-Chromium {PtCr}, Nitinol], and Polymer
• Coronary Stents Market Segmentation By End-User: Hospitals, Ambulatory Surgical Centers, and Others
• Coronary Stents Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Coronary Stents Companies: Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cook, Scitech Medical, Lepu Medical Technology (Beijing) Co., Ltd., OrbusNeich Medical Group Holdings Limited, Cordis, Johnson & Johnson Services, Inc., ENDOCOR GmbH & CO. KG, BD, Vascular Concepts, Translumina, Elixir Medical, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Coronary Stents market will grow by 2030? Click to get a snapshot of the Coronary Stents Market Analysis
https://www.delveinsight.com/sample-request/coronary-stents-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Coronary Stents Market Report Introduction
2 Coronary Stents Market Executive summary
3 Regulatory and Patent Analysis
4 Coronary Stents Market Key Factors Analysis
5 Porter's Five Forces Analysis
6 COVID-19 Impact Analysis on Coronary Stents Market
7 Coronary Stents Market Layout
8 Global Company Share Analysis - Key 3-5 Companies
9 Company and Product Profiles
10 Project Approach
11 Coronary Stents Market Drivers
12 Coronary Stents Market Barriers
13 About DelveInsight

Latest Reports by DelveInsight
• Scoliosis Market: https://www.delveinsight.com/report-store/scoliosis-market
• Psoriasis Market: https://www.delveinsight.com/report-store/psoriasis-market
• Tendinitis Market: https://www.delveinsight.com/report-store/tendonitis-market
• Vascular Closure Devices Market: https://www.delveinsight.com/report-store/vascular-closure-devices-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Hydrocephalus Market: https://www.delveinsight.com/report-store/hydrocephalus-market
• Hemophilia A Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Herpes Simplex Virus Market: https://www.delveinsight.com/report-store/genital-herpes-market
• Peripheral Nerve Injuries Market: https://www.delveinsight.com/infographics/peripheral-nerve-injuries-market

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Coronary Stents Market to grow at a CAGR of 7.51% by 2030, Evaluates DelveInsight | Medtronic, Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun SE, Terumo Corporation, MicroPo here

News-ID: 4072960 • Views:

More Releases from DelveInsight Business Research

Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Companies
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, DelveInsight Finds
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics. DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,

All 5 Releases


More Releases for Stent

Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period. The future outlook for the airway stent lung
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion. Market Revenue Growth The global airway stent/lung stent market is on an
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients